Diacylglycerol kinase and phospholipase D inhibitors alter the cellular lipidome and endosomal sorting towards the Golgi apparatus

Cell Mol Life Sci. 2021 Feb;78(3):985-1009. doi: 10.1007/s00018-020-03551-6. Epub 2020 May 23.

Abstract

The membrane lipids diacylglycerol (DAG) and phosphatidic acid (PA) are important second messengers that can regulate membrane transport by recruiting proteins to the membrane and by altering biophysical membrane properties. DAG and PA are involved in the transport from the Golgi apparatus to endosomes, and we have here investigated whether changes in these lipids might be important for regulation of transport to the Golgi using the protein toxin ricin. Modulation of DAG and PA levels using DAG kinase (DGK) and phospholipase D (PLD) inhibitors gave a strong increase in retrograde ricin transport, but had little impact on ricin recycling or degradation. Inhibitor treatment strongly affected the endosome morphology, increasing endosomal tubulation and size. Furthermore, ricin was present in these tubular structures together with proteins known to regulate retrograde transport. Using siRNA to knock down different isoforms of PLD and DGK, we found that several isoforms of PLD and DGK are involved in regulating ricin transport to the Golgi. Finally, by performing lipidomic analysis we found that the DGK inhibitor gave a weak, but expected, increase in DAG levels, while the PLD inhibitor gave a strong and unexpected increase in DAG levels, showing that it is important to perform lipidomic analysis when using inhibitors of lipid metabolism.

Keywords: CAY10594; Intracellular transport; PLD3; R59022; SNX2; Vps35.

MeSH terms

  • Cell Line, Tumor
  • Diacylglycerol Kinase / antagonists & inhibitors
  • Diacylglycerol Kinase / genetics
  • Diacylglycerol Kinase / metabolism*
  • Diglycerides / metabolism
  • Endocytosis / drug effects
  • Endosomes / metabolism*
  • Enzyme Inhibitors / pharmacology
  • Golgi Apparatus / metabolism*
  • Humans
  • Lipidomics / methods
  • Lipids / analysis
  • Phospholipase D / antagonists & inhibitors
  • Phospholipase D / genetics
  • Phospholipase D / metabolism*
  • Protein Isoforms / antagonists & inhibitors
  • Protein Isoforms / genetics
  • Protein Isoforms / metabolism
  • Protein Transport / drug effects
  • Proteolysis / drug effects
  • Pyrimidinones / pharmacology
  • RNA Interference
  • RNA, Small Interfering / metabolism
  • Ricin / metabolism
  • Thiazoles / pharmacology

Substances

  • Diglycerides
  • Enzyme Inhibitors
  • Lipids
  • Protein Isoforms
  • Pyrimidinones
  • RNA, Small Interfering
  • Thiazoles
  • Ricin
  • R 59022
  • Diacylglycerol Kinase
  • Phospholipase D